A Systematic Review of Eczematous Eruptions in Patients Receiving Biologic Therapy

The development of biologic agents has revolutionized treatment for immune-mediated inflammatory diseases (IMIDs). An infrequently reported cutaneous complication in the literature is the development of dermatitis during therapy. This systematic review summarizes relevant reports of dermatitis eruptions in patients receiving biologic therapy for IMIDs. The supplemental files are attached here.

生物制剂的研发彻底革新了免疫介导性炎症性疾病（IMIDs）的治疗方法。在文献中，皮疹作为治疗过程中的一种不常报道的皮肤并发症引起了广泛关注。本系统综述综合了接受IMIDs生物治疗患者中皮疹发作的相关报道。附加文件已在此处附上。